Drugs formulary review of Icosapent Ethyl (FOI)
Drugs formulary review of Icosapent Ethyl (FOI)Produced by the Bailiff's Chamber
Authored by Government of Jersey and published on 26 January 2023.
Prepared internally, no external costs.
Has Icosapent Ethyl been reviewed?
If not, has Icosapent Ethyl been allocated as an agenda item on an upcoming committee(s) meeting?
Name of the person who has completed the ‘formulary paperwork’ on behalf of the drug that will be shared with the committee(s).
Icosapent Ethyl has not been reviewed by the Pharmaceutical Benefit Advisory Committee.
Icosapent Ethyl does not appear on a forthcoming agenda.
No application to add Icosapent Ethyl to the prescribed list has been received.